Directorio de personas
Luis Brieva Ruiz

Luis Brieva Ruiz

Grado: Doctor/a

973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3812-2011

Publicaciones

  • Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J

    A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS

    MULTIPLE SCLEROSIS JOURNAL 20 717-725. .

    [doi:10.1177/1352458513508835]

  • Fernández Ó; Arnal-García C; Arroyo-González R; Brieva L; Calles-Hernández MC; Casanova-Estruch B; Comabella M; de las Heras V; García-Merino JA; Hernández-Pérez MA; Izquierdo G; Matas E; Meca-Lallana JE; Mendibe-Bilbao Mdel M; Muñoz-García D; Olascoaga J; Oreja-Guevara C; Prieto JM; Ramió-Torrentà L; Rodríguez-Antigüedad A; Saiz A; Téllez N; Villar LM; Tintoré M; Post-ECTRIMS Group

    Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III)

    REVISTA DE NEUROLOGIA 57 317-329. .

  • Fernandez, Oscar; Arnal-Garcia, Carmen; Arroyo-Gonzalez, Rafael; Brieva, Lluis; Carmen Calles-Hernandez, M.; Casanova-Estruch, Bonaventura; Comabella, Manuel; de las Heras, Virginia; Garcia-Merino, Juan A.; Hernandez-Perez, Miguel A.; Izquierdo, Guillermo; Matas, Elisabet; Meca-Lallana, Jose E.; del Mar Mendibe-Bilbao, Maria; Munoz-Garcia, Delicias; Olascoaga, Javier; Oreja-Guevara, Celia; Prieto, Jose M.; Ramio-Torrenta, Lluis; Rodriguez-Antigueedad, Alfredo; Saiz, Albert; Tellez, Nieves; Villar, Luisa M.; Tintore, Mar; Grupo Post-ECTRIMS

    Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

    REVISTA DE NEUROLOGIA 57 269-281. .

  • Fernandez, Oscar; Arnal-Garcia, Carmen; Arroyo-Gonzalez, Rafael; Brieva, Lluis; Carmen Calles-Hernandez, M.; Casanova-Estruch, Bonaventura; Comabella, Manuel; de las Heras, Virginia; Garcia-Merino, Juan A.; Hernandez-Perez, Miguel A.; Izquierdo, Guillermo; Matas, Elisabet; Meca-Lallana, Jose E.; del Mar Mendibe-Bilbao, Maria; Munoz-Garcia, Delicias; Olascoaga, Javier; Oreja-Guevara, Celia; Prieto, Jose M.; Ramio-Torrenta, Lluis; Rodriguez-Antigueedad, Alfredo; Saiz, Albert; Tellez, Nieves; Villar, Luisa M.; Tintore, Mar; Grp Post-ECTRIMS

    Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)

    REVISTA DE NEUROLOGIA 57 217-229. .

  • Huerva V; March A; Sánchez MC; Brieva L

    Síndrome de ápex orbitario como comienzo de linfoma B de células grandes

    REVISTA CLINICA ESPANOLA 213 37-38. .

    [doi:10.1016/j.rce.2012.07.009]

  • Gonzalo, Hugo; Brieva, Luis; Tatzber, Franz; Jove, Mariona; Cacabelos, Daniel; Cassanye, Anna; Lanau-Angulo, Lucia; Boada, Jordi; Serrano, Jose C. E.; Gonzalez, Cristina; Hernandez, Lourdes; Peralta, Silvia; Pamplona, Reinald; Portero-Otin, Manuel

    Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism

    JOURNAL OF NEUROCHEMISTRY 123 622-634. .

    [doi:10.1111/j.1471-4159.2012.07934.x]

  • Fernandez, Oscar; Alvarez-Cermeno, Jose C.; Arroyo-Gonzalez, Rafael; Brieva, Lluis; Iles-Hernandez, M. Carmen Ca; Casanova-Estruch, Bonaventura; Comabella, Manuel; Heras, Virginia de las; Garcia-Merino, Juan A.; Hernandez-Perez, Miguel A.; Izguierdo, Guillermo; Meca-Lallana, Jose E.; Munoz-Garcia, Delicias; Olascoaga, Javier; Oreja-Guevara, Celia; Prieto, Jose M.; Ramio-Torrenta, Lluis; Rodriguez-Antiguedad, Alfredo; Romero-Pinel, Lucia; Sanchez, Fernando; Tellez, Nieves; Tintore, Mar; Montalban, Xavier; Post-Ectrims, G

    Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

    REVISTA DE NEUROLOGIA 54 734-749. .

  • Fernandez, Oscar; Alvarez-Cermeno, Jose C.; Arroyo-Gonzalez, Rafael; Brieva, Lluis; Carmen Calles-Hernandez, M.; Casanova-Estruch, Bonaventura; Comabella, Manuel; de las Heras, Virginia; Garcia-Merino, Juan A.; Hernandez-Perez, Miguel A.; Izguierdo, Guillermo; Meca-Lallana, Jose E.; Munoz-Garcia, Delicias; Olascoaga, Javier; Oreja-Guevara, Celia; Prieto, Jose M.; Ramio-Torrenta, Lluis; Rodriguez-Antigueedad, Alfredo; Romero-Pinel, Lucia; Sanchez, Fernando; Tellez, Nieves; Tintore, Mar; Montalban, Xavier; Grp Post-ECTRIMS

    Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)

    REVISTA DE NEUROLOGIA 54 677-691. .

  • Comi, Giancarlo; Jeffery, Douglas; Kappos, Ludwig; Montalban, Xavier; Boyko, Alexey; Rocca, Maria A.; Filippi, Massimo; ALLEGRO Study Grp

    Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

    NEW ENGLAND JOURNAL OF MEDICINE 366 1000-1009. .

  • Comi G; Jeffery D; Kappos L; Montalban X; Boyko A; Rocca MA; Filippi M; ALLEGRO Study Group

    Placebo-controlled trial of oral laquinimod for multiple sclerosis.

    NEW ENGLAND JOURNAL OF MEDICINE 366 1000-1009. .

    [doi:10.1056/NEJMoa1104318]

  • Purroy, Francisco; Montserrat, Josep; Begue, Robert; Isabel Gil, Maria; Quilez, Alejandro; Sanahuja, Jordi; Brieva, Luis; Pardina, Marina; Pinol-Ripoll, Gerard

    Higher carotid intima media thickness predicts extracranial vascular events and not stroke recurrence among transient ischemic attack patients

    INTERNATIONAL JOURNAL OF STROKE 7 125-132. .

    [doi:10.1111/j.1747-4949.2011.00764.x]

  • Tur C; Montalban X; Tintoré M; Nos C; Río J; Aymerich FX; Brieva L; Téllez N; Perkal H; Comabella M; Galán I; Calle D; Sastre-Garriga J; Rovira A

    Interferon ß-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

    ARCHIVES OF NEUROLOGY 68 1421-1427. .

    [doi:10.1001/archneurol.2011.241]

Proyectos

  • EMCOVID-19: Esclerosis Múltiple y COVID-19
  • "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
  • UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO